Citation

Haffen E. Encephale (1974) 2007; 33(Suppl 5): 180-186.

Copyright

(Copyright © 2007, Masson Editeur)

DOI

10.1016/S0013-7006(07)78699-2

PMID

unavailable

Abstract

[Abstract unavailable]

Language: fr

Keywords

human; suicide; prevalence; schizophrenia; mortality; clinical trial; risk assessment; clozapine; risk factor; article; neuroleptic agent; disease predisposition; smoking; drug metabolism; levomepromazine; amfebutamone; fluoxetine; moclobemide; paroxetine; sertraline; quetiapine; haloperidol; thioridazine; sudden death; placebo; olanzapine; QT interval; risperidone; methadone; unindexed drug; chlorpromazine; drug effect; side effect; cimetidine; diabetes mellitus; ziprasidone; heart arrhythmia; QT prolongation; cytochrome P450 3A4; sertindole; torsade des pointes; perphenazine; ciprofloxacin; fluphenazine; phenothiazine; cytochrome P450 1A2; cytochrome P450 2D6; long QT syndrome; zuclopenthixol; enoxacin; molindone